Active temperature controlled company Swiss Airtainer, has gained pre-round A investment from a consortium of private investors. The company, which has already received startup grants from venture capital sources, including the Swiss Federal Office of Civil Aviation for its initial development phase, said the new investment will help it meet the growing demand for its containers, which have been validated by pharmaceutical companies, airlines and logistics providers. The funding will enable the company to accelerate production and expand its market presence.
Swiss Airtainer’s says it active temperature-controlled offer lower weight and reduce CO2 emissions by 45%, saving four tons of CO2 on a round-trip between Zurich and San Francisco.
The containers offer redundancy in critical components, for example with solar panels backed up by six high-energy lightweight batteries for consistent and precise temperature control during flight and transit, even under challenging conditions. Airtainer also says they offer industry-first, true two-way GSM-based communication capabilities, enabling real-time tracking, alerts, and preventive intervention.
They have approval from regulatory bodies, including the European Union Aviation Safety Agency (EASA) and the Federal Aviation Administration (FAA).
Chief executive Eduard Seligman said: “This funding will help us to scale up and move closer to our goal. The trust that several major pharmaceutical companies have already placed in Swiss Airtainer demonstrates the strength of our product and its potential to transform cold chain logistics.”
Chairman of the board, Dr Ludwig Bertsch, added: “With its modern technology and focus on research and development, Swiss Airtainer provides pharmaceutical companies with a greener and more cost-effective alternative and continues to push the boundaries of what’s possible in cold chain logistics.”